Israel Chemicals Ltd (ICL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | 466,000 | 820,000 | N/A |
| Depreciation Amortization | 427,000 | 348,000 | N/A |
| Income taxes - deferred | 37,000 | N/A | N/A |
| Accounts receivable | -25,000 | 20,000 | N/A |
| Accounts payable and accrued liabilities | -22,000 | -85,000 | N/A |
| Other Working Capital | -14,000 | -7,000 | N/A |
| Other Operating Activity | 24,000 | 31,000 | 0 |
| Operating Cash Flow | $893,000 | $1,127,000 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -835,000 | -824,000 | N/A |
| Net Acquisitions | -143,000 | -63,000 | N/A |
| Sale Of Investment | -21,000 | 46,000 | N/A |
| Purchase Sale Intangibles | N/A | -22,000 | N/A |
| Other Investing Activity | 3,000 | 1,000 | 0 |
| Investing Cash Flow | $-996,000 | $-840,000 | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | -140,000 | 263,000 | N/A |
| Debt Repayment | 1,056,000 | 62,000 | N/A |
| Dividend Paid | -845,000 | -634,000 | N/A |
| Other Financing Activity | -1,000 | 0 | 0 |
| Financing Cash Flow | $70,000 | $-309,000 | $N/A |
| Exchange Rate Effect | -16,000 | 4,000 | N/A |
| Beginning Cash Position | 188,000 | 206,000 | N/A |
| End Cash Position | 131,000 | 188,000 | N/A |
| Net Cash Flow | $-57,000 | $-18,000 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | 893,000 | 1,127,000 | N/A |
| Capital Expenditure | -835,000 | -827,000 | N/A |
| Free Cash Flow | 58,000 | 300,000 | 0 |